Cardiovascular disease in the elderly;Enfermedad cardiovascular en el anciano

Revista Espanola de Cardiologia

Volumn 64, Issue 8, 2011, Pages 697-712

  Jackson, Charles F ^a   Wenger, Nanette K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aortic valve stenosis; Clinical trials; Coronary disease; Geriatric medicine

Indexed keywords

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CAUSE OF DEATH; CLINICAL TRIAL (TOPIC); COMORBIDITY; EVIDENCE BASED MEDICINE; GERIATRIC CARE; GERIATRIC DISORDER; GERIATRIC PATIENT; HUMAN; INDEPENDENCE; LONGEVITY; NON INVASIVE PROCEDURE; TRADITIONAL MEDICINE; TREATMENT RESPONSE;

AGE FACTORS; AGED; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HEART FAILURE; HEART VALVE DISEASES; HUMANS;

EID: 80053051051     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.05.001     Document Type: Article

References (170)

1. Centers for Disease Control and Prevention. Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003; 52:101-4, 106.
2. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
3. E.G. Lakatta Central arterial aging and the epidemic of systolic hypertension and atherosclerosis J Am Soc Hypertens 1 2007 302 340 (Pubitemid 47454438)
4. E.G. Lakatta, and D. Levy Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease Circulation 107 2003 139 146 (Pubitemid 36070946)
5. M. Wang, R.E. Monticone, and E.G. Lakatta Arterial aging: a journey into subclinical arterial disease Curr Opin Nephrol Hypertens 19 2010 201 207
6. Y. Maruyama Aging and arterial-cardiac interactions in the elderly Int J Cardiol 2011 Feb 11 [Epub ahead of print]
7. A.M. Dart, and B.A. Kingwell Pulse pressure - a review of mechanisms and clinical relevance J Am Coll Cardiol 37 2001 975 984 (Pubitemid 32217593)
8. M.E. Safar, B.I. Levy, and H. Struijker-Boudier Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases Circulation 107 2003 2864 2869 (Pubitemid 36705999)
9. K.G. Pugh, and J.Y. Wei Clinical implications of physiological changes in the aging heart Drugs Aging 18 2001 263 276 (Pubitemid 32391814)
10. E.G. Lakatta, and D. Levy Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease Circulation 107 2003 346 354 (Pubitemid 36135235)
11. G. Gerstenblith, J. Frederiksen, F.C. Yin, N.J. Fortuin, E.G. Lakatta, and M.L. Weisfeldt Echocardiographic assessment of a normal adult aging population Circulation 56 1977 273 278 (Pubitemid 8247487)
12. B.S. Burlew, and K.T. Weber Cardiac fibrosis as a cause of diastolic dysfunction Herz 27 2002 92 98 (Pubitemid 34309394)
13. M. Lindroos, M. Kupari, J. Heikkila, and R. Tilvis Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample J Am Coll Cardiol 21 1993 1220 1225 (Pubitemid 23106200)
14. S.M. Gharacholou, B.L. Karon, C. Shub, and P.A. Pellikka Aortic valve sclerosis and clinical outcomes: moving toward a definition Am J Med 124 2011 103 110
15. J.E. Cosmi, S. Kort, P.A. Tunick, B.P. Rosenzweig, R.S. Freedberg, and E.S. Katz The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening Arch Intern Med 162 2002 2345 2347 (Pubitemid 35332517)
16. S. Pepe, and E.G. Lakatta Aging hearts and vessels: masters of adaptation and survival Cardiovasc Res 66 2005 190 193 (Pubitemid 40471033)
17. M. Frenneaux, and L. Williams Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling Prog Cardiovasc Dis 49 2007 252 262 (Pubitemid 44918058)
18. D.A. Kass Ventricular arterial stiffening: integrating the pathophysiology Hypertension 46 2005 185 193 (Pubitemid 40946512)
19. N. Craft, and J.B. Schwartz Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans Am J Physiol 268 4 Pt 2 1995 H1441 H1452
20. P. Weidmann, S. De Myttenaere-Bursztein, M.H. Maxwell, and J. De Lima Effect on aging on plasma renin and aldosterone in normal man Kidney Int 8 1975 325 333
21. F.C. Luft, C.E. Grim, N. Fineberg, and M.C. Weinberger Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages Circulation 59 1979 643 650 (Pubitemid 9154955)
22. I.J. Deary, J. Corley, A.J. Gow, S.E. Harris, L.M. Houlihan, and R.E. Marioni Age-associated cognitive decline Br Med Bull 92 2009 135 152
23. H. Axer, M. Axer, H. Sauer, O.W. Witte, and G. Hagemann Falls and gait disorders in geriatric neurology Clin Neurol Neurosurg 112 2010 265 274
24. R.W. Motl, and E. McAuley Physical activity, disability, and quality of life in older adults Phys Med Rehabil Clin North Am 21 2010 299 308
25. F.C. Ko The clinical care of frail, older adults Clin Geriatr Med 27 2011 89 100
26. L.A. Stevens, and A.S. Levey Chronic kidney disease in the elderly - how to assess risk N Engl J Med 352 2005 2122 2124 (Pubitemid 40664314)
27. M. Cirillo, P. Anastasio, and N.G. De Santo Relationship of gender, age, and body mass index to errors in predicted kidney function Nephrol Dial Transplant 20 2005 1791 1798 (Pubitemid 41222590)
28. E.S. Huang, R. Gorawara-Bhat, and M.H. Chin Self-reported goals of older patients with type 2 diabetes mellitus J Am Geriatr Soc 53 2005 306 311 (Pubitemid 41632559)
29. A.S. Morrow, P. Haidet, J. Skinner, and A.D. Naik Integrating diabetes self-management with the health goals of older adults: a qualitative exploration Patient Educ Couns 72 2008 418 423
30. B. Iung, G. Baron, E.G. Butchart, F. Delahaye, C. Gohlke-Barwolf, and O.W. Levang A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243 (Pubitemid 36834640)
31. B. Iung, A. Cachier, G. Baron, D. Messika-Zeitoun, F. Delahaye, and P. Tornos Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720 (Pubitemid 41746694)
32. B.J. Bouma, R.B. Van den Brink, J.H. Van der Meulen, H.A. Verheul, E.C. Cheriex, and H.P. Hamer To operate or not on elderly patients with aortic stenosis: the decision and its consequences Heart 82 1999 143 148 (Pubitemid 29362861)
33. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, and F. Bauer Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008 (Pubitemid 35440280)
34. A. Linke, T. Walther, and G. Schuler The utility of trans-catheter aortic valve replacement after commercialization: does the European experience provide a glimpse into the future use of this technology in the United States? Catheter Cardiovasc Interv 75 2010 511 518
35. J. Webb, and A. Cribier Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J 32 2011 140 147
36. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
37. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. De Leon Jr., D.P. Faxon, and M.D. Freed 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e1 e142
38. B. Iung, and A. Vahanian Epidemiology of valvular heart disease in the adult Nat Rev Cardiol 8 2011 162 172
39. E.A. Grossi, A.C. Galloway, G.H. Ribakove, P.M. Buttenheim, R. Esposito, and F.G. Baumann Minimally invasive port access surgery reduces operative morbidity for valve replacement in the elderly Heart Surg Forum 2 1999 212 215
40. J. Lamelas, A. Sarria, O. Santana, A.M. Pineda, and G.A. Lamas Outcomes of minimally invasive valve surgery versus median sternotomy in patients age 75 years or greater Ann Thorac Surg 91 2011 79 84
41. P. Modi, A. Hassan, and W.R. Chitwood Jr. Minimally invasive mitral valve surgery: a systematic review and meta-analysis Eur J Cardiothorac Surg 34 2008 943 952
42. T. Feldman, S. Kar, M. Rinaldi, P. Fail, J. Hermiller, and R. Smalling Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort J Am Coll Cardiol 54 2009 686 694
43. P.T. Chiam, and C.E. Ruiz Percutaneous transcatheter mitral valve repair: a classification of the technology JACC Cardiovasc Intervention 4 2011 1 13
44. T. Feldman, E. Foster, D.G. Glower, S. Kar, M.J. Rinaldi, and P.S. Fail Percutaneous repair or surgery for mitral regurgitation N Engl J Med 364 2011 1395 1406
45. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
46. N.S. Beckett, R. Peters, A.E. Fletcher, J.A. Staessen, L. Liu, and D. Dumitrascu Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898 (Pubitemid 351620109)
47. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
48. J. Shepherd, G.J. Blauw, M.B. Murphy, E.L. Bollen, B.M. Buckley, and S.M. Cobbe Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 2002 1623 1630 (Pubitemid 35379733)
49. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
50. N.K. Wenger, S.J. Lewis, D.M. Herrington, V. Bittner, and F.K. Welty Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease Ann Intern Med 147 2007 1 9 (Pubitemid 351664628)
51. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
52. R.J. Glynn, W. Koenig, B.G. Nordestgaard, J. Shepherd, and P.M. Ridker Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial Ann Intern Med 152 2010 488 496 W174
53. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
54. W.E. Boden, R.A. O'Rourke, K.K. Teo, P.M. Hartigan, D.J. Maron, and W.J. Kostuk Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
55. K.K. Teo, S.P. Sedlis, W.E. Boden, R.A. O'Rourke, D.J. Maron, and P.M. Hartigan Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial J Am Coll Cardiol 54 2009 1303 1308
56. M. Pfisterer, P. Buser, S. Osswald, U. Allemann, W. Amann, and W. Angehrn Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial JAMA 289 2003 1117 1123 (Pubitemid 37430325)
57. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
58. T.D. Fraker Jr., S.D. Fihn, R.J. Gibbons, J. Abrams, K. Chatterjee, and J. Daley 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina J Am Coll Cardiol 50 2007 2264 2274 (Pubitemid 350166813)
59. R. Kones Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization Vasc Health Risk Manag 6 2010 749 774
60. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
61. M. Gianni, J. Bosch, J. Pogue, J. Probstfield, G. Dagenais, and S. Yusuf Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients Eur Heart J 28 2007 1382 1388 (Pubitemid 47355976)
62. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
63. E. Braunwald, M.J. Domanski, S.E. Fowler, N.L. Geller, B.J. Gersh, and J. Hsia Angiotensin-converting-enzyme inhibition in stable coronary artery disease N Engl J Med 351 2004 2058 2068
64. G.R. Dagenais, J. Pogue, K. Fox, M.L. Simoons, and S. Yusuf Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials Lancet 368 2006 581 588 (Pubitemid 44209181)
65. R.E. Goldstein, S.J. Boccuzzi, D. Cruess, and S. Nattel Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group Circulation 83 1991 52 60
66. M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, and R.N. Belkin Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N Engl J Med 335 1996 1107 1114 (Pubitemid 26330964)
67. P.A. Poole-Wilson, J. Lubsen, B.A. Kirwan, F.J. Van Dalen, G. Wagener, and N. Danchin Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial Lancet 364 2004 849 857 (Pubitemid 39221062)
68. C. Sierra, and A. Coca The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension Expert Rev Cardiovasc Ther 6 2008 1055 1062
69. P.H. Stone, N.A. Gratsiansky, A. Blokhin, I.Z. Huang, and L. Meng Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial J Am Coll Cardiol 48 2006 566 575 (Pubitemid 44093970)
70. M.W. Rich, M. Crager, and C.R. McKay Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectoris Am J Geriatr Cardiol 16 2007 216 221
71. K.P. Alexander, L.K. Newby, C.P. Cannon, P.W. Armstrong, W.B. Gibler, and M.W. Rich Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2549 2569 (Pubitemid 46766536)
72. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
73. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e426 e579
74. R.J. Peters, S.R. Mehta, K.A. Fox, F. Zhao, B.S. Lewis, and S.L. Kopecky Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 2003 1682 1687 (Pubitemid 37243654)
75. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, and S. Gottlieb Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
76. The PRISM-PLUS Study Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med 338 1998 1488 1497
77. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy N Engl J Med 339 1998 436 443
78. D. Hasdai, D.R. Holmes Jr., D.A. Criger, E.J. Topol, R.M. Califf, and R.A. Harrington Age and outcome after acute coronary syndromes without persistent ST-segment elevation Am Heart J 139 2000 858 866 (Pubitemid 30305408)
79. E. Boersma, R.A. Harrington, D.J. Moliterno, H. White, P. Theroux, and F. Van de Werf Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198 (Pubitemid 34113814)
80. R.P. Giugliano, J.A. White, C. Bode, P.W. Armstrong, G. Montalescot, and B.S. Lewis Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med 360 2009 2176 2190
81. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, and J.W. Moses Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
82. R.D. Lopes, K.P. Alexander, S.V. Manoukian, M.E. Bertrand, F. Feit, and H.D. White Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 53 2009 1021 1030
83. R.D. Lopes, and K.P. Alexander Antiplatelet therapy in older adults with non-ST-segment elevation acute coronary syndrome: considering risks and benefits Am J Cardiol 104 5 Suppl 2009 C16 C21
84. S. Yusuf, S.R. Mehta, S. Chrolavicius, R. Afzal, J. Pogue, and C.B. Granger Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
85. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, and N. Lakkis Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887 (Pubitemid 32564900)
86. R.J. De Winter, F. Windhausen, J.H. Cornel, P.H. Dunselman, C.L. Janus, and P.E. Bendermacher Early invasive versus selectively invasive management for acute coronary syndromes N Engl J Med 353 2005 1095 1104 (Pubitemid 41317432)
87. K.A. Fox, T.C. Clayton, P. Damman, S.J. Pocock, R.J. De Winter, and J.G. Tijssen Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data J Am Coll Cardiol 55 2010 2435 2445
88. K.P. Alexander, L.K. Newby, P.W. Armstrong, C.P. Cannon, W.B. Gibler, and M.W. Rich Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2570 2589 (Pubitemid 46766537)
89. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
90. H.D. White Thrombolytic therapy in the elderly Lancet 356 2000 2028 2030 (Pubitemid 32009815)
91. F.G. Kushner, M. Hand, S.C. Smith Jr., S.B. King 3rd, J.L. Anderson, and E.M. Antman 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
92. H.D. White, G.I. Barbash, R.M. Califf, R.J. Simes, C.B. Granger, and W.D. Weaver Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial Circulation 94 1996 1826 1833 (Pubitemid 26349293)
93. F. Van de Werf, H.V. Barron, P.W. Armstrong, C.B. Granger, S. Berioli, and G. Barbash Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA Eur Heart J 22 2001 2253 2261 (Pubitemid 34000980)
94. L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A. Adgey, and H.R. Arntz Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142 (Pubitemid 36871293)
95. E.M. Antman, D.A. Morrow, C.H. McCabe, S.A. Murphy, M. Ruda, and Z. Sadowski Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med 354 2006 1477 1488
96. M.J. De Boer, J.P. Ottervanger, A.W. Van 't Hof, J.C. Hoorntje, H. Suryapranata, and F. Zijlstra Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy J Am Coll Cardiol 39 2002 1723 1728 (Pubitemid 34595279)
97. C. Grines, A. Patel, F. Zijlstra, W.D. Weaver, C. Granger, and R.J. Simes Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials Am Heart J 145 2003 47 57 (Pubitemid 36034497)
98. E. Boersma Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients Eur Heart J 27 2006 779 788
99. W.S. Aronow Etiology, pathophysiology, and treatment of atrial fibrillation: part 1 Cardiol Rev 16 2008 181 188
100. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, and E.B. Schron A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
101. D.G. Wyse Rate control vs rhythm control strategies in atrial fibrillation Prog Cardiovasc Dis 48 2005 125 138 (Pubitemid 41505376)
102. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, and K.L. Lee Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
103. I.C. Van Gelder, H.F. Groenveld, H.J. Crijns, Y.S. Tuininga, J.G. Tijssen, and A.M. Alings Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
104. T. Yamada, and G.N. Kay Catheter ablation of atrial fibrillation in the elderly Pacing Clin Electrophysiol 32 2009 1085 1091
105. R. Marinigh, G.Y. Lip, N. Fiotti, C. Giansante, and D.A. Lane Age as a risk factor for stroke in atrial fibrillation patients implications for thromboprophylaxis: Implications for thromboprophylaxis J Am Coll Cardiol 56 2010 827 837
106. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
107. C. Van Walraven, R.G. Hart, G.A. Wells, P. Petersen, P.J. Koudstaal, and A.L. Gullov A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin Arch Intern Med 163 2003 936 943 (Pubitemid 36519739)
108. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906 (Pubitemid 44175743)
109. D. Capodanno, and D.J. Angiolillo Antithrombotic therapy in the elderly J Am Coll Cardiol 56 2010 1683 1692
110. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696 (Pubitemid 46842784)
111. J. Mant, F.D. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, and G.Y. Lip Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503 (Pubitemid 47212371)
112. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
113. N.E. Schwartz, and G.W. Albers Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation Stroke 41 2010 1307 1309
114. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
115. S.J. Connolly, M. Gent, R.S. Roberts, P. Dorian, D. Roy, and R.S. Sheldon Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302 (Pubitemid 30158618)
116. K.H. Kuck, R. Cappato, J. Siebels, and R. Ruppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754 (Pubitemid 30648765)
117. S.J. Connolly, A.P. Hallstrom, R. Cappato, E.B. Schron, K.H. Kuck, and D.P. Zipes Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study Eur Heart J 21 2000 2071 2078
118. J.S. Healey, A.P. Hallstrom, K.H. Kuck, G. Nair, E.P. Schron, and R.S. Roberts Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias Eur Heart J 28 2007 1746 1749 (Pubitemid 47227082)
119. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes 3rd, R.A. Freedman, and L.S. Gettes ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
120. J.T. Bigger Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators N Engl J Med 337 1997 1569 1575 (Pubitemid 27509759)
121. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
122. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, and D.S. Cannom Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
123. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, and R. Hatala Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488 (Pubitemid 39603155)
124. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, and K.P. Anderson Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158 (Pubitemid 38637995)
125. A.S. Desai, J.C. Fang, W.H. Maisel, and K.L. Baughman Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879 (Pubitemid 39628235)
126. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, and R. Boineau Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
127. D.T. Huang, H.W. Sesselberg, S. McNitt, K. Noyes, M.L. Andrews, and W.J. Hall Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy J Cardiovasc Electrophysiol 18 2007 833 838 (Pubitemid 47093069)
128. P.W. Groeneveld, S.A. Farmer, J.J. Suh, M.A. Matta, and F. Yang Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly Heart Rhythm 5 2008 646 653
129. S.R. Kaufman, P.S. Mueller, A.L. Ottenberg, and B.A. Koenig Ironic technology: Old age and the implantable cardioverter defibrillator in US health care Soc Sci Med 72 2011 6 14
130. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
131. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 4 Suppl A 1993 A6 A13
132. J.B. Croft, W.H. Giles, R.A. Pollard, N.L. Keenan, M.L. Casper, and R.F. Anda Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population Arch Intern Med 159 1999 505 510 (Pubitemid 29108917)
133. S.A. Hunt ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 e82
134. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 273 1995 1450 1456
135. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
136. G. Gambassi, K.L. Lapane, A. Sgadari, P. Carbonin, C. Gatsonis, and L.A. Lipsitz Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology Arch Intern Med 160 2000 53 60 (Pubitemid 30040973)
137. B. Pitt, R. Segal, F.A. Martinez, G. Meurers, A.J. Cowley, and I. Thomas Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet 349 1997 747 752 (Pubitemid 27122456)
138. B. Pitt, P.A. Poole-Wilson, R. Segal, F.A. Martinez, K. Dickstein, and A.J. Camm Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II Lancet 355 2000 1582 1587 (Pubitemid 30240502)
139. J.N. Cohn, and G. Tognoni A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675 (Pubitemid 33126822)
140. M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, and E.L. Michelson Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766 (Pubitemid 37093915)
141. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, and P. Mohacsi Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658 (Pubitemid 32479962)
142. CIBIS II Investigators Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
143. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
144. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, and E.M. Gilbert The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355 (Pubitemid 26152713)
145. B.R. Dulin, S.J. Haas, W.T. Abraham, and H. Krum Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials Am J Cardiol 95 2005 896 898 (Pubitemid 40386810)
146. M.D. Flather, M.C. Shibata, A.J. Coats, D.J. Van Veldhuisen, A. Parkhomenko, and J. Borbola Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225 (Pubitemid 40222359)
147. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
148. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321 (Pubitemid 36384098)
149. F. Zannad, J.J. McMurray, H. Krum, D.J. Van Veldhuisen, K. Swedberg, and H. Shi Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
150. D.N. Juurlink, M.M. Mamdani, D.S. Lee, A. Kopp, P.C. Austin, and A. Laupacis Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551 (Pubitemid 39025171)
151. J.N. Cohn, D.G. Archibald, S. Ziesche, J.A. Franciosa, W.E. Harston, and F.E. Tristani Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1552 (Pubitemid 16114684)
152. J.N. Cohn, D.G. Archibald, G.S. Francis, S. Ziesche, J.A. Franciosa, and W.E. Harston Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate Circulation 75 5 Pt 2 1987 IV49 IV54
153. J.N. Cohn, G. Johnson, S. Ziesche, F. Cobb, G. Francis, and F. Tristani A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
154. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., and K. Ferdinand Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
155. G. Johnson, P. Carson, G.S. Francis, and J.N. Cohn Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group Circulation 87 6 Suppl 1993 VI32 VI39
156. A.L. Taylor, S. Ziesche, C.W. Yancy, P. Carson, K. Ferdinand, and M. Taylor Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial Circulation 115 2007 1747 1753 (Pubitemid 46648611)
157. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group N Engl J Med 336 1997 525 533
158. M.W. Rich, F. McSherry, W.O. Williford, and S. Yusuf Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study J Am Coll Cardiol 38 2001 806 813 (Pubitemid 32835757)
159. A.L. Aarnoudse, J.P. Dieleman, and B.H. Stricker Age- and gender-specific incidence of hospitalisation for digoxin intoxication Drug Saf 30 2007 431 436 (Pubitemid 46740339)
160. A. Ahmed, J.B. Young, T.E. Love, R. Levesque, and B. Pitt A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure Int J Cardiol 125 2008 246 253 (Pubitemid 351400220)
161. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
162. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. De Marco Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
163. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
164. J. Kron, J.M. Aranda Jr., W.M. Miles, T.A. Burkart, G.W. Woo, and S.J. Saxonhouse Benefit of cardiac resynchronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials J Interv Card Electrophysiol 25 2009 91 96
165. J. Kron, and J.B. Conti Cardiac resynchronization therapy for treatment of heart failure in the elderly Heart Fail Clin 3 2007 511 518 (Pubitemid 47465105)
166. D.W. Kitzman, J.M. Gardin, J.S. Gottdiener, A. Arnold, R. Boineau, and G. Aurigemma Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study Am J Cardiol 87 2001 413 419 (Pubitemid 32149998)
167. D.W. Kitzman, and K.R. Daniel Diastolic heart failure in the elderly Heart Fail Clin 3 2007 437 453 (Pubitemid 47465101)
168. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, and J.J. McMurray Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781 (Pubitemid 37093918)
169. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, and M.R. Zile Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
170. D.E. Forman, M.W. Rich, K.P. Alexander, S. Zieman, M.S. Maurer, and S.S. Najjar Cardiac care for older adults time for a new paradigm J Am Coll Cardiol 57 2011 1801 1810